AZD3293 + Placebo
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
Conditions
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
Trial Timeline
Dec 1, 2013 → Jul 1, 2014
NCT ID
NCT02005211About AZD3293 + Placebo
AZD3293 + Placebo is a phase 1 stage product being developed by AstraZeneca for Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT02005211. Target conditions include Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers.
What happened to similar drugs?
20 of 20 similar drugs in Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02005211 | Phase 1 | Completed |
| NCT01795339 | Phase 1 | Completed |
| NCT01739647 | Phase 1 | Completed |
Competing Products
20 competing products in Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |